Brief: Vyant Bio Posts Q1 Loss Per Share Of $2.31
May 17 (Reuters) - Vyant Bio Inc VYNT.O :
* VYANT BIO REPORTS FIRST QUARTER 2021 RESULTS AND PROVIDES
STRATEGIC BUSINESS UPDATE
* Q1 REVENUE ROSE 32 PERCENT TO $222,000
* QTRLY LOSS PER SHARE $2.31
Source text for Eikon: ID:nGNX6n64XG
Further company coverage: VYNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration